From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi‐layer antihypertensive tablets
暂无分享,去创建一个
Peter Timmins | Muzna Sadia | Abdullah Isreb | Mohammad Isreb | Mohamed A. Alhnan | M. Isreb | M. Sadia | P. Timmins | A. Isreb | Ibrahim Abbadi | David Aziz | Amjad Selo | Amjad Selo | David Aziz | M. Alhnan | Ibrahim Abbadi | Abdullah Isreb
[1] M. Peeters,et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial , 2004, The Lancet.
[2] M. Alexander,et al. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[3] A. Garber,et al. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[4] A. Basit,et al. Effect of geometry on drug release from 3D printed tablets. , 2015, International journal of pharmaceutics.
[5] R. Manzo,et al. Interaction between Eudragit® E100 and anionic drugs: addition of anionic polyelectrolytes and their influence on drug release performance. , 2011, Journal of pharmaceutical sciences.
[6] N. Fan,et al. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms. , 2017, Molecular pharmaceutics.
[7] S. Pocock,et al. to improve adherence : results from FOCUS ( Fixed-dose Combination Drug for Secondary Cardiovascular Prevention ) Project , 2014 .
[8] M. A. Alhnan,et al. A flexible-dose dispenser for immediate and extended release 3D printed tablets. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] C Vervaet,et al. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] B. Pharm.,et al. THE BRITISH PHARMACOPOEIA. , 1964, The Medical annals of the District of Columbia.
[11] Waqar Ahmed,et al. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. , 2016, International journal of pharmaceutics.
[12] D. S. Bell. Combine and conquer: advantages and disadvantages of fixed‐dose combination therapy , 2013, Diabetes, obesity & metabolism.
[13] R. Manzo,et al. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] P. Nandy,et al. Analysis of dose–response in flexible dose titration clinical studies , 2012, Pharmaceutical statistics.
[15] A. Basit,et al. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] B. Arafat,et al. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets , 2016, Pharmaceutical Research.
[17] S. Bangalore,et al. Fixed-dose combinations improve medication compliance: a meta-analysis. , 2007, American Journal of Medicine.
[18] Y. Gupta,et al. Fixed dose drug combinations: Issues and challenges in India , 2016, Indian journal of pharmacology.
[19] Simon Gaisford,et al. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. , 2015, Molecular pharmaceutics.
[20] Waqar Ahmed,et al. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[21] K. Fukushige,et al. 3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets. , 2017, Biological & pharmaceutical bulletin.
[22] M. A. Alhnan,et al. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Hao Pan,et al. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. , 2017, International journal of pharmaceutics.
[24] H. Wen,et al. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms , 2013, Pharmaceutical development and technology.
[25] A. Basit,et al. Fused-filament 3D printing (3DP) for fabrication of tablets. , 2014, International journal of pharmaceutics.
[26] Hugh Smyth,et al. 3D Printing technologies for drug delivery: a review , 2016, Drug development and industrial pharmacy.
[27] Basel Arafat,et al. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy , 2016, Pharmaceutical Research.
[28] Shun-Li Wang,et al. Eudragit E Accelerated the Diketopiperazine Formation of Enalapril Maleate Determined by Thermal FTIR Microspectroscopic Technique , 2004, Pharmaceutical Research.
[29] M. Alexander,et al. 3D printing of tablets containing multiple drugs with defined release profiles. , 2015, International journal of pharmaceutics.
[30] D. Dollimore,et al. A THERMAL ANALYSIS STUDY OF THE DECOMPOSITION OF HYDROCHLOROTHIAZIDE , 2002 .
[31] H. Woerle,et al. Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double‐blind, placebo‐controlled study , 2012, Diabetes, obesity & metabolism.
[32] Xiangrong Zhang,et al. A promising choice in hypertension treatment: Fixed-dose combinations , 2014 .
[33] F. Zannad,et al. Benefits, challenges, and registerability of the polypill. , 2006, European heart journal.
[34] Wei Xu,et al. Structure determination of enalapril maleate form II from high-resolution X-ray powder diffraction data. , 2003, Journal of pharmaceutical sciences.
[35] R. Hatcher. THE UNITED STATES PHARMACOPEIA. , 1908 .
[36] Basel Arafat,et al. A Lower Temperature FDM 3 D Printing for the Manufacture of Patient Specific Immediate Release , 2019 .
[37] S. Onoue,et al. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability. , 2012, Drug metabolism and pharmacokinetics.
[38] Waqar Ahmed,et al. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges , 2016, Pharmaceutical Research.